Get the Stockscreener App
0.4569
0.91%
-0.0032
Scienture Holdings Inc stock is traded at $0.4569, with a volume of 245.25K.
It is down -0.91% in the last 24 hours and up +7.27% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
See More
Previous Close:
$0.4601
Open:
$0.4643
24h Volume:
245.25K
Relative Volume:
0.08
Market Cap:
$18.54M
Revenue:
$653.40K
Net Income/Loss:
$-20.19M
P/E Ratio:
-0.2526
EPS:
-1.8091
Net Cash Flow:
$-11.11M
1W Performance:
-6.00%
1M Performance:
+7.27%
6M Performance:
-45.23%
1Y Performance:
-74.24%
1-Day Range:
$0.4439
$0.4702
1-Week Range:
$0.4322
$0.4919
52-Week Range:
$0.372
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.4564 | 18.69M | 653.40K | -20.19M | -11.11M | -1.8091 |
HITI
High Tide Inc
|
2.31 | 198.65M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.31 | 48.79M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.3026 | 39.33M | 0 | 0 | 0 | 0.00 |
WGRX
Wellgistics Health Inc
|
0.1206 | 10.44M | 23.34M | -101.27M | -11.74M | -1.2919 |
Scienture Holdings Inc Stock (SCNX) Latest News
If You Invested $1,000 in Scienture Holdings, Inc (SCNX) - Stock Titan
Gap Down: What are analysts price targets for Scienture Holdings Inc2026 Technical Overview & Expert Approved Trade Ideas - baoquankhu1.vn
Scienture Holdings Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Exclusive: Scienture expands reach for opioid overdose treatment, with deals covering 60% of US institutional market - MSN
Scienture secures GPO deals for naloxone nasal spray By Investing.com - Investing.com Nigeria
Scienture Holdings regains compliance with Nasdaq listing requirements - MSN
Scienture Holdings files to sell 2.1M shares for holders - MSN
Scienture (SCNX) Co-CEO adds stock grants and converts preferred into common - Stock Titan
Scienture files $200M mixed securities shelf - MSN
Scienture secures GPO deals for naloxone nasal spray - Investing.com India
SCNX Expands Market Reach with New GPO Agreements - GuruFocus
SCIENTURE Broadens Commercial Access for REZENOPY, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - Bitget
SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - The Manila Times
High-dose overdose spray REZENOPY set to reach 5,000 US care sites - Stock Titan
EXCLUSIVE: Scienture Expands Reach For Opioid Overdose Treatment, With Deals Covering 60% Of US Institutional Market - Benzinga
Total current assets of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
What makes Scienture Holdings Inc. stock attractive to growth funds2025 AllTime Highs & High Conviction Buy Zone Alerts - Naître et grandir
Why Scienture Holdings Inc. stock remains a top recommendationMarket Activity Recap & Daily Profit Focused Stock Screening - Naître et grandir
Is Scienture Holdings Inc. stock a top pick in earnings seasonWeekly Trade Review & Proven Capital Preservation Tips - Naître et grandir
Why Is Scienture Stock Rising Today? - Stocktwits
SCNX SEC FilingsScienture Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
SCNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SCNX Earnings History & Surprises | EPS & Revenue Results | SCIENTURE HOLDINGS INC (NASDAQ:SCNX) - ChartMill
Aug Spikes: What is Scienture Holdings Incs market position2025 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
SCNX Should I Buy - Intellectia AI
Scienture Holdings, Inc.: Target Price Consensus and Analysts Recommendations | | US80880X1046 - marketscreener.com
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | | US80880X1046 - marketscreener.com
SCNX Technical Analysis & Stock Price Forecast - Intellectia AI
Scienture Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | SCNX | US80880X1046 - marketscreener.com
Scienture (NASDAQ:SCNX) Coverage Initiated by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage on Scienture Holdings (SCNX) with a 'Buy' Rating | SCNX Stock News - GuruFocus
Maxim Group Initiates Coverage of Scienture Holdings (SCNX) with Buy Recommendation - Nasdaq
Maxim Group Initiates Coverage on Scienture (NASDAQ:SCNX) - National Today
What are analysts’ price targets for Scienture Holdings Inc.2025 Year in Review & Fast Gaining Stock Reports - mfd.ru
Aug Movers: What is Scienture Holdings Incs market positionWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Gainers Report: What is Scienture Holdings Incs market positionBond Market & Weekly Breakout Stock Alerts - baoquankhu1.vn
Why Scienture Holdings Inc. (4E4) stock is upgraded to buyProfit Target & Long-Term Safe Investment Plans - mfd.ru
Is Scienture Holdings Inc. stock a good pick for beginnersJuly 2025 Highlights & Low Risk Profit Maximizing Plans - mfd.ru
Aug Levels: Is Scienture Holdings Inc stock heavily shortedWeekly Profit Analysis & Smart Swing Trading Alerts - baoquankhu1.vn
Scienture reports progress on ARBLI, confirms REZENOPY launch By Investing.com - Investing.com Nigeria
SCNX: Scienture Updates on Arbli and Future Product Launch - GuruFocus
Scienture reports progress on ARBLI, confirms REZENOPY launch - Investing.com
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture Provides Commercial Update on ARBLI , the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium - marketscreener.com
Signal Recap: Does InvenTrust Properties Corp stock have upside surprise potentialAnalyst Downgrade & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Is Scienture Holdings Inc gaining market share2025 Technical Overview & AI Enhanced Trading Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Scienture appoints Hariharan, Mani as co-CEOs - MSN
Growth Value: Will Scienture Holdings Inc benefit from geopolitical trendsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
EPS Watch: What is Scienture Holdings Incs book value per share2025 Technical Overview & Expert Approved Momentum Ideas - baoquankhu1.vn
Risk On: Is Scienture Holdings Inc stock heavily shortedMarket Risk Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Scienture Holdings Inc Stock (SCNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.26%
10.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):